9880 Campus Point Drive
4 articles with RayzeBio, Inc.
RayzeBio Expands Leadership Team With Susan Moran, M.D., as Chief Medical Officer; Kimberly Ma, M.S., as SVP of Clinical Operations; and Nicholas Smith, Ph.D., as SVP of Chemistry Innovation
RayzeBio, Inc. today announced that three senior management team members across clinical development and research have joined the company.
6/16/2021Each week more money pours into the biopharma world. Here's a peek at who's getting a taste of fresh funds this week.
RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer
RayzeBio, Inc., oday announced a $108 million Series C financing led by Venrock Healthcare Capital Partners alongside new investors Perceptive Advisors, Vivo Capital, Acuta Capital Partners, Deerfield Management, and TCG X.
Umoja Biopharma, Alentis Therapeutics, RayzeBio and Camp4 Therapeutics are ramping up on series funds.